Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
14M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
91.3K
-
Shares change
-
+74.3K
-
Total reported value, excl. options
-
$221K
-
Value change
-
+$217K
-
Number of buys
-
9
-
Number of sells
-
-1
-
Price
-
$2.42
Significant Holders of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) as of Q4 2024
10 filings reported holding MGRX - MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share as of Q4 2024.
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.3K shares
of 14M outstanding shares and own 0.65% of the company stock.
Largest 10 shareholders include Ackerman Capital Advisors, LLC (34.5K shares), Virtu Financial LLC (20.5K shares), HRT FINANCIAL LP (13.5K shares), GEODE CAPITAL MANAGEMENT, LLC (12K shares), Federation des caisses Desjardins du Quebec (4.6K shares), Tower Research Capital LLC (TRC) (2.63K shares), Steward Partners Investment Advisory, LLC (2.09K shares), UBS Group AG (1.52K shares), BANK OF AMERICA CORP /DE/ (11 shares), and CAPTRUST FINANCIAL ADVISORS (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.